Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients - Look, MP; Putten, WLJ; van Duffy, MJ (J Natl Cancer Inst, 2002)
et al.